Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elastosis perforans serpiginosa.

Tina Suneja1, Beth Zelonis, M Yadira Hurley

  • 1Denver Dermatology Consultants PC, Denver, CO, USA. toffee108@gmail.com

Skinmed
|September 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatofibroma Hypocellularity Is Associated With Patient Age: A Retrospective Study of 307 Cases.

Journal of cutaneous pathology·2026
Same author

Case Series of Ocular Oncocytoma of the Caruncle, Conjunctiva, and Eyelid.

Journal of cutaneous pathology·2026
Same author

Fontana-Masson Staining in Aneurysmal and Hemosiderotic Dermatofibromas: A Study of 79 Cases.

Journal of cutaneous pathology·2026
Same author

Diffuse Large B-Cell Lymphoma Transdifferentiating Into Histiocytic Sarcoma: Case Report + Systematic Review.

Journal of cutaneous pathology·2025
Same author

Demographics of U.S. Dermatopathology Fellowship Applicant Interviewees: A Single Institution Descriptive Analysis.

Journal of cutaneous pathology·2025
Same author

Spiradenocarcinoma With Associated Mucinous Glandular Differentiation: A Unique Histopathologic Presentation of a Rare Diagnosis.

The American Journal of dermatopathology·2025
Same journal

Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.

Skinmed·2025
Same journal

Racial Disparities in the Management of Atopic Dermatitis: An Analysis of the National Ambulatory Medical Care Survey, 2012-2018.

Skinmed·2025
Same journal

"Pseudo-Chik Sign" Following COVID-19: Pigmentation Hitherto Unreported.

Skinmed·2025
Same journal

Hyperpigmented Scaly Lesions in the Axillae.

Skinmed·2025
Same journal

Sweet Syndrome-Like Disorder Induced by the Oxford-AstraZeneca<sup>®</sup> SARS-CoV-2 Vaccine.

Skinmed·2025
Same journal

Lockdown Lessons from Dermatology Consultations during the COVID-19 Pandemic in a Tertiary Care Center.

Skinmed·2025
See all related articles

This case study describes elastosis perforans serpiginosa, a rare skin condition, in a man with Down syndrome. The diagnosis was confirmed by biopsy showing abnormal elastin extrusion through the epidermis.

Area of Science:

  • Dermatology
  • Histopathology
  • Genetics

Background:

  • Down syndrome is a genetic disorder associated with various dermatological conditions.
  • Elastosis perforans serpiginosa (EPS) is a rare benign reactive perforating disorder of the skin.

Observation:

  • A 41-year-old man with Down syndrome presented with a chronic, pruritic, papular eruption on his forearms.
  • The lesions were characterized by keratotic, umbilicated pink papules in an annular configuration, with surrounding hyperpigmentation and atrophy.

Findings:

  • Histopathological examination revealed extrusion of bright red fibers, identified as abnormal elastin, through an acanthotic epidermis.
  • Special stains confirmed the presence of abnormal elastin, leading to the diagnosis of elastosis perforans serpiginosa.

Related Experiment Videos

Implications:

  • This case highlights a rare cutaneous manifestation in an individual with Down syndrome.
  • Understanding the histopathological features of EPS is crucial for accurate diagnosis and management.
  • Further research may explore potential links between genetic factors in Down syndrome and the development of elastosis perforans serpiginosa.